Article
Omalizumab for the Treatment of Allergic Rhinitis: A Systematic Review and Meta-Analysis
2024-01-30
Abstract excerpt
<h4>Background: </h4> Allergic rhinitis (AR), an IgE-mediated inflammatory disease, significantly impacts the quality of life of a considerable proportion of the general population. Omalizumab, a humanized monoclonal antibody against IgE, has been evaluated for both seasonal and perennial AR. We aimed to assess the efficacy and safety of omalizumab in randomized controlled trials (RCTs) in inadequately controlled...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0eac636d-b992-570d-9d1c-6ea4fe7ebf45
- DOI
- 10.22541/au.170665836.66308695/v1
